Peter Benedict's most recent trade in Usana Health Sciences Inc was a trade of 4,553 Common Stock done at an average price of $19.4 . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Sale of securities on an exchange or to another person at price $ 19.38 per share. | 03 Mar 2026 | 4,553 | 0 (0%) | 0% | 19.4 | 88,259 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 3,906 | 38,602 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 3,906 | 5,727 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.52 per share. | 27 Feb 2026 | 1,174 | 4,553 (0%) | 0% | 21.5 | 25,264 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 21,775 | 42,508 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 1,157 | 2,222 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 1,157 | 20,733 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 1,000 | 1,000 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 1,000 | 22,521 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 631 | 1,284 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 631 | 21,890 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.34 per share. | 06 Feb 2026 | 401 | 1,821 (0%) | 0% | 21.3 | 8,557 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.34 per share. | 06 Feb 2026 | 347 | 653 (0%) | 0% | 21.3 | 7,405 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.34 per share. | 06 Feb 2026 | 219 | 1,065 (0%) | 0% | 21.3 | 4,673 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Sale of securities on an exchange or to another person at price $ 20.95 per share. | 10 Dec 2025 | 2,673 | 0 (0%) | 0% | 21.0 | 56,001 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2025 | 598 | 23,521 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2025 | 598 | 2,849 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.95 per share. | 25 Jul 2025 | 176 | 2,673 (0%) | 0% | 31.9 | 5,623 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 15,625 | 24,119 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,157 | 8,494 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,157 | 2,652 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 658 | 1,724 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 658 | 9,651 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 401 | 2,251 (0%) | 0% | 30.7 | 12,291 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 229 | 1,495 (0%) | 0% | 30.7 | 7,019 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,001 | 1,001 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,001 | 10,941 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 632 | 1,286 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 632 | 10,309 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 347 | 654 (0%) | 0% | 31.2 | 10,830 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 220 | 1,066 (0%) | 0% | 30.7 | 6,743 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,391 | 16,462 | - | - | Restricted Stock Units |